EDP 305
EDP 305-003
Phase 1 small_molecule completed
Quick answer
EDP 305 for NASH is a Phase 1 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ENANTA PHARMACEUTICALS INC
- Indication
- NASH
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed